Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine receptor SNP polymorphisms and caffeine response in apnea of prematurity
ChiCTR1800015609Phase 3Not yet recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: SNP genotypes of patient groups, Incidence of bronchopulmonary dysplasia and 1 more. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on ChiCTR1800015609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015609.